Privi Speciality Chemicals Limited

NSEI:PRIVISCL 주식 보고서

시가총액: ₹72.4b

Privi Speciality Chemicals 과거 수익 실적

과거 기준 확인 4/6

Privi Speciality Chemicals의 수입은 연평균 -21.4%의 비율로 감소해 온 반면, Chemicals 산업은 수입이 연평균 14.6%의 비율로 증가했습니다. 매출은 연평균 4.1%의 비율로 증가해 왔습니다. Privi Speciality Chemicals의 자기자본이익률은 13.6%이고 순이익률은 7.2%입니다.

주요 정보

-21.4%

수익 성장률

-21.8%

EPS 성장률

Chemicals 산업 성장17.7%
매출 성장률4.1%
자기자본 수익률13.6%
순이익7.2%
최근 수익 업데이트30 Sep 2024

최근 과거 실적 업데이트

Recent updates

Privi Speciality Chemicals Limited's (NSE:PRIVISCL) Business Is Trailing The Market But Its Shares Aren't

Jan 15
Privi Speciality Chemicals Limited's (NSE:PRIVISCL) Business Is Trailing The Market But Its Shares Aren't

These 4 Measures Indicate That Privi Speciality Chemicals (NSE:PRIVISCL) Is Using Debt Extensively

Nov 17
These 4 Measures Indicate That Privi Speciality Chemicals (NSE:PRIVISCL) Is Using Debt Extensively

Some Confidence Is Lacking In Privi Speciality Chemicals Limited's (NSE:PRIVISCL) P/S

Oct 14
Some Confidence Is Lacking In Privi Speciality Chemicals Limited's (NSE:PRIVISCL) P/S

Privi Speciality Chemicals Limited (NSE:PRIVISCL) Looks Just Right With A 28% Price Jump

Jun 25
Privi Speciality Chemicals Limited (NSE:PRIVISCL) Looks Just Right With A 28% Price Jump

Privi Speciality Chemicals (NSE:PRIVISCL) Takes On Some Risk With Its Use Of Debt

Jun 04
Privi Speciality Chemicals (NSE:PRIVISCL) Takes On Some Risk With Its Use Of Debt

What Privi Speciality Chemicals Limited's (NSE:PRIVISCL) 25% Share Price Gain Is Not Telling You

Apr 30
What Privi Speciality Chemicals Limited's (NSE:PRIVISCL) 25% Share Price Gain Is Not Telling You

Does Privi Speciality Chemicals (NSE:PRIVISCL) Have A Healthy Balance Sheet?

Sep 05
Does Privi Speciality Chemicals (NSE:PRIVISCL) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Privi Speciality Chemicals (NSE:PRIVISCL) Is Using Debt Extensively

Mar 10
These 4 Measures Indicate That Privi Speciality Chemicals (NSE:PRIVISCL) Is Using Debt Extensively

Does Privi Speciality Chemicals (NSE:PRIVISCL) Have A Healthy Balance Sheet?

Sep 21
Does Privi Speciality Chemicals (NSE:PRIVISCL) Have A Healthy Balance Sheet?

Privi Speciality Chemicals (NSE:PRIVISCL) Has A Somewhat Strained Balance Sheet

Jun 21
Privi Speciality Chemicals (NSE:PRIVISCL) Has A Somewhat Strained Balance Sheet

Here's Why Privi Speciality Chemicals (NSE:PRIVISCL) Has A Meaningful Debt Burden

Feb 15
Here's Why Privi Speciality Chemicals (NSE:PRIVISCL) Has A Meaningful Debt Burden

Is Privi Speciality Chemicals (NSE:PRIVISCL) A Risky Investment?

May 24
Is Privi Speciality Chemicals (NSE:PRIVISCL) A Risky Investment?

Trade Alert: The Independent Director Of Privi Speciality Chemicals Limited (NSE:PRIVISCL), Anurag Surana, Has Just Spent ₹9.9m Buying 200% More Shares

Feb 26
Trade Alert: The Independent Director Of Privi Speciality Chemicals Limited (NSE:PRIVISCL), Anurag Surana, Has Just Spent ₹9.9m Buying 200% More Shares

Shareholders of Privi Speciality Chemicals (NSE:PRIVISCL) Must Be Delighted With Their 359% Total Return

Feb 24
Shareholders of Privi Speciality Chemicals (NSE:PRIVISCL) Must Be Delighted With Their 359% Total Return

Does Privi Speciality Chemicals (NSE:PRIVISCL) Have A Healthy Balance Sheet?

Jan 31
Does Privi Speciality Chemicals (NSE:PRIVISCL) Have A Healthy Balance Sheet?

What To Know Before Buying Privi Speciality Chemicals Limited (NSE:PRIVISCL) For Its Dividend

Jan 16
What To Know Before Buying Privi Speciality Chemicals Limited (NSE:PRIVISCL) For Its Dividend

Privi Speciality Chemicals Limited's (NSE:PRIVISCL) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Jan 03
Privi Speciality Chemicals Limited's (NSE:PRIVISCL) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Is Privi Speciality Chemicals Limited's (NSE:PRIVISCL) Shareholder Ownership Skewed Towards Insiders?

Dec 21
Is Privi Speciality Chemicals Limited's (NSE:PRIVISCL) Shareholder Ownership Skewed Towards Insiders?

Read This Before Selling Privi Speciality Chemicals Limited (NSE:PRIVISCL) Shares

Dec 08
Read This Before Selling Privi Speciality Chemicals Limited (NSE:PRIVISCL) Shares

If You Had Bought Privi Speciality Chemicals (NSE:PRIVISCL) Shares Five Years Ago You'd Have Earned 124% Returns

Nov 25
If You Had Bought Privi Speciality Chemicals (NSE:PRIVISCL) Shares Five Years Ago You'd Have Earned 124% Returns

Are Privi Speciality Chemicals's (NSE:PRIVISCL) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Nov 12
Are Privi Speciality Chemicals's (NSE:PRIVISCL) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Is It Smart To Buy Privi Speciality Chemicals Limited (NSE:PRIVISCL) Before It Goes Ex-Dividend?

Oct 21
Is It Smart To Buy Privi Speciality Chemicals Limited (NSE:PRIVISCL) Before It Goes Ex-Dividend?

Privi Speciality Chemicals Limited (NSE:FAIRCHEM) Is An Attractive Dividend Stock - Here's Why

Oct 12
Privi Speciality Chemicals Limited (NSE:FAIRCHEM) Is An Attractive Dividend Stock - Here's Why

Does Fairchem Speciality (NSE:FAIRCHEM) Have A Healthy Balance Sheet?

Sep 27
Does Fairchem Speciality (NSE:FAIRCHEM) Have A Healthy Balance Sheet?

A Piece Of The Puzzle Missing From Fairchem Speciality Limited's (NSE:FAIRCHEM) Share Price

Sep 14
A Piece Of The Puzzle Missing From Fairchem Speciality Limited's (NSE:FAIRCHEM) Share Price

The Independent Director of Fairchem Speciality Limited (NSE:FAIRCHEM), Anurag Surana, Just Bought 400% More Shares

Aug 28
The Independent Director of Fairchem Speciality Limited (NSE:FAIRCHEM), Anurag Surana, Just Bought 400% More Shares

Should We Be Excited About The Trends Of Returns At Fairchem Speciality (NSE:FAIRCHEM)?

Aug 18
Should We Be Excited About The Trends Of Returns At Fairchem Speciality (NSE:FAIRCHEM)?

Is Fairchem Speciality Limited's (NSE:FAIRCHEM) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Aug 03
Is Fairchem Speciality Limited's (NSE:FAIRCHEM) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Did Fairchem Speciality Limited (NSE:FAIRCHEM) Insiders Buy Up More Shares?

Jul 19
Did Fairchem Speciality Limited (NSE:FAIRCHEM) Insiders Buy Up More Shares?

Is Fairchem Speciality's (NSE:FAIRCHEM) Share Price Gain Of 120% Well Earned?

Jul 07
Is Fairchem Speciality's (NSE:FAIRCHEM) Share Price Gain Of 120% Well Earned?

Fairchem Speciality (NSE:FAIRCHEM) Is Growing Earnings But Are They A Good Guide?

Jun 25
Fairchem Speciality (NSE:FAIRCHEM) Is Growing Earnings But Are They A Good Guide?

수익 및 비용 분석

Privi Speciality Chemicals 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

NSEI:PRIVISCL 수익, 비용 및 수입 (INR Millions )
날짜수익수익G+A 비용R&D 비용
30 Sep 2418,8491,3587780
30 Jun 2418,0751,2177500
31 Mar 2417,5229497270
31 Dec 2316,6665027490
30 Sep 2316,8262717410
30 Jun 2316,277457650
31 Mar 2316,0782227970
31 Dec 2215,8606588000
30 Sep 2215,6078518050
30 Jun 2214,6029057870
31 Mar 2214,0379747670
31 Dec 2113,8001,2737330
30 Sep 2113,1251,2127050
30 Jun 2113,1961,2497170
31 Mar 2112,7661,1697000
31 Dec 2015,3911,2248740
30 Sep 2015,2181,3508670
30 Jun 2015,0271,6078210
31 Mar 2013,2411,4606520
31 Dec 1916,7371,8198240
30 Sep 1916,6182,1358020
30 Jun 1915,5431,6557580
31 Mar 1913,4109427170
31 Dec 1812,1496826570
30 Sep 1811,089866360
30 Jun 1810,4931036080
31 Mar 1810,2435345790
31 Dec 179,3282936160
30 Sep 178,3192625790
30 Jun 177,6592575150
31 Mar 175,9732713590
31 Dec 161,727128990
30 Sep 161,686138930
30 Jun 161,590141830
31 Mar 161,517106780
31 Dec 151,468861310
30 Sep 151,452791280
30 Jun 151,458911260
31 Mar 151,506137750
31 Dec 141,5831711220
30 Sep 141,6051961170
30 Jun 141,6392111140
31 Mar 141,5181871100

양질의 수익: PRIVISCL 은 높은 수익을 보유하고 있습니다.

이익 마진 증가: PRIVISCL 의 현재 순이익 이익률 (7.2%) 작년보다 높습니다 (1.6%).


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: PRIVISCL 의 수입은 지난 5년 동안 매년 21.4% 씩 감소했습니다.

성장 가속화: 지난 1년간 PRIVISCL 의 수익 증가율( 401.5% )은 연간 평균( -21.4% 초과합니다. ).

수익 대 산업: 지난 1년간 PRIVISCL 수익 증가율( 401.5% )은 Chemicals 업계 9.6% 초과했습니다.


자기자본 수익률

높은 ROE: PRIVISCL 의 자본 수익률( 13.6% )은 낮음으로 간주됩니다.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기

기업 분석 및 재무 데이터 현황

데이터마지막 업데이트(UTC 시간)
기업 분석2025/01/20 16:18
장 마감 주가2025/01/20 00:00
수익2024/09/30
연간 수익2024/03/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
회사 재무10년
  • 손익 계산서
  • 현금 흐름표
  • 대차 대조표
애널리스트 컨센서스 추정치+3년
  • 재무 예측
  • 애널리스트 목표가
시장 가격30년
  • 주식 가격
  • 배당금, 분할 및 액션
소유권10년
  • 최대 주주
  • 내부자 거래
관리10년
  • 리더십 팀
  • 이사회
주요 개발 사항10년
  • 회사 공지 사항

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

Privi Speciality Chemicals Limited 4 애널리스트 중 0 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가교육기관
null nullAsian Markets Securities Private Limited
Kameswari V. S. ChavaliFirstCall Research
Chintan ModiHaitong International Research Limited